Events Imaging Nuclear Medicine Radiation 
AuntMinnie
JULY 12, 2024
As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Image courtesy of Washington University. "We Nuclear Regulatory Commission and is an integral part of a theranostics practice.
AuntMinnie
SEPTEMBER 16, 2024
The World Health Organization (WHO) on September 17 will offer a webinar on the importance of accurate and timely diagnoses in ensuring patient safety that will include discussion of medical imaging and radiation exposure. to 1:30 p.m. to 1:30 p.m. Central European Time. Those interested in attending can register here.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
MARCH 26, 2024
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
AuntMinnie
JUNE 14, 2024
Nuclear medicine injection extravasations and medical events will be the focus of the Advisory Committee on the Medical Uses of Isotopes (ACMUI)'s public teleconference on June 17. I hope you won't make that a medical event because that would be ridiculous. That might do away with diagnostic concerns, Flannery noted.
AuntMinnie
JUNE 8, 2024
An emerging radioligand therapy could be particularly effective for controlling advanced sarcoma compared to other cancers, according to research presented June 8 in a Young Investigator Award session at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Toronto. Image courtesy of SNMMI.
AuntMinnie
MAY 8, 2024
Three clinical issues that may arise with theranostics treatments will require special provisions, including spot imaging, according to insights shared during the 124th annual meeting of the American Roentgen Ray Society (ARRS) in Boston. It causes radiation injury that may be visible as dry desquamation or moist desquamation, for example.
AuntMinnie
JUNE 20, 2024
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
Expert insights. Personalized for you.
105 
Let's personalize your content